New drug MT-501 tested in humans for first time
Knowledge-focused
Completed
This early-stage study tested the safety and tolerability of a new drug called MT-501 in 72 healthy adults aged 19 to 55. Participants received either the drug or a placebo to check for side effects and how the drug moves through the body. The goal was not to treat any disease, b…
Phase: PHASE1 • Sponsor: Mirador Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:03 UTC